Publication | Closed Access

Specific intravenous carbohydrate therapy: a new approach to the inhibition of antibody-mediated rejection following ABO-incompatible allografting and discordant xenografting.

Discordant XenograftingXenotransplantationTransplantationImmunosuppressive TherapyImmunologyHematologyPharmacologyAbo-incompatible AllograftingAntibody-mediated RejectionGraft SurvivalAntibody EngineeringGraft RejectionImmunotherapyMedicineCell TransplantationTransplant Immunology